nach oben

International Urology and Nephrology

Erschienen in:

27.05.2020 | Nephrology - Original Paper

Lower circulating soluble Klotho level is associated with increased risk of all-cause mortality in chronic kidney disease patients: a systematic review and meta-analysis

verfasst von: Nipith Charoenngam, Ben Ponvilawan, Patompong Ungprasert

Erschienen in: International Urology and Nephrology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to investigate the association between circulating soluble Klotho level and risk of all-cause mortality in chronic kidney disease (CKD) patients using systematic review and meta-analysis technique.

Methods

Potentially eligible studies were identified from Medline and EMBASE databases from inception to March 2020 using a search strategy that consisted of terms for “Klotho” and “Mortality”. Eligible study must be a cohort study that consists of one cohort of CKD patients with higher circulating soluble Klotho level and another cohort of CKD patients with lower circulating soluble Klotho level. The study must also report relative risk (RR), incidence rate ratio, hazard risk ratio or standardized incidence ratio with 95% confidence intervals (95% CIs) comparing all-cause mortality between CKD patients with lower circulating soluble Klotho level versus CKD patients with higher circulating soluble Klotho level. If the study divides patients (per circulating soluble Klotho level) into more than two groups, a comparison between the highest and the lowest group would be extracted. Point estimates with standard errors were retrieved from each study and were combined together using the generic inverse variance method.

Results

A total of 2964 articles were retrieved. After two rounds of an independent review by two investigators, six prospective cohort studies met the eligibility criteria and were included into the meta-analysis. CKD patients with lower circulating soluble Klotho level had a significantly increased risk of all-cause mortality with the pooled risk ratio of 1.88 (95% CI 1.29–2.74; I² 0%). The funnel plot was fairly symmetric and did not reveal any suggestive evidence of publication bias.

Conclusion

The current study found a significant association between lower circulating soluble Klotho level and increased risk of all-cause mortality in CKD patients. However, this meta-analysis carries some limitations, including relatively small sample size, lack of adjustment for potential confounders and between-study heterogeneity in baseline characteristics of the patients and cut-off values used to categorize patients into higher and lower circulating serum Klotho level group.

Nur mit Berechtigung zugänglich

Xu Y, Sun Z (2015) Molecular basis of Klotho: from gene to function in aging. Endocr Rev 36(2):174–193. https://doi.org/10.1210/er.2013-1079 PubMedPubMedCentralCrossRef

Hu MC, Shi M, Zhang J, Addo T, Cho HJ, Barker SL, Ravikumar P, Gillings N, Bian A, Sidhu SS, Kuro-o M, Moe OW (2016) Renal production, uptake, and handling of circulating α Klotho. J Am Soc Nephrol 27(1):79–90. https://doi.org/10.1681/ASN.2014101030 PubMedCrossRef

Kim J-H, Hwang K-H, Park K-S, Kong ID, Cha S-K (2015) Biological role of anti-aging protein Klotho. J Lifestyle Med 5(1):1–6. https://doi.org/10.15280/jlm.2015.5.1.1 PubMedPubMedCentralCrossRef

Dalton GD, Xie J, An S-W, Huang C-L (2017) New insights into the mechanism of action of soluble Klotho. Front Endocrinol 8:323CrossRef

Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M (2005) Suppression of aging in mice by the hormone Klotho. Science 309(5742):1829–1833. https://doi.org/10.1126/science.1112766 PubMedPubMedCentralCrossRef

Dubal DB, Zhu L, Sanchez PE, Worden K, Broestl L, Johnson E, Ho K, Yu G-Q, Kim D, Betourne A, Kuro-o M, Masliah E, Abraham CR, Mucke L (2015) Life extension factor Klotho prevents mortality and enhances cognition in hAPP transgenic mice. J Neurosci 35(6):2358. https://doi.org/10.1523/JNEUROSCI.5791-12.2015 PubMedPubMedCentralCrossRef

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY-M, Yang C-W (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382(9888):260–272. https://doi.org/10.1016/S0140-6736(13)60687-X PubMedCrossRef

Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ (2003) Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41(1):47–55. https://doi.org/10.1016/S0735-1097(02)02663-3 PubMedCrossRef

Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, Tonelli M (2015) Cause of death in patients with reduced kidney function. J Am Soc Nephrol 26(10):2504. https://doi.org/10.1681/ASN.2014070714 PubMedPubMedCentralCrossRef

10.

Hu MC, Kuro-o M, Moe OW (2013) Klotho and chronic kidney disease. Contrib Nephrol 180:47–63. https://doi.org/10.1159/000346778 PubMedPubMedCentralCrossRef

11.

Kuro-o M (2018) Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications? Nephrol Dial Transplant 34(1):15–21. https://doi.org/10.1093/ndt/gfy126 CrossRef

12.

Otani-Takei N, Masuda T, Akimoto T, Honma S, Watanabe Y, Shiizaki K, Miki T, Kusano E, Asano Y, Kuro OM, Nagata D (2015) Association between serum soluble Klotho levels and mortality in chronic hemodialysis patients. Int J Endocrinol. https://doi.org/10.1155/2015/406269 PubMedPubMedCentralCrossRef

13.

Zheng S, Zheng Y, Jin L, Zhou Z, Li Z (2018) Relationship between serum soluble Klotho protein and coronary artery calcification and prognosis in patients on maintenance hemodialysis. Iran J Public Health 47(4):510–518PubMedPubMedCentral

14.

Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, Shin DH, Doh FM, Koo HM, Ko KI, Kim CH, Oh HJ, Yoo TH, Kang SW, Han DS, Han SH (2013) Circulating α-klotho levels in CKD and relationship to progression. Am J Kidney Dis 61(6):899–909. https://doi.org/10.1053/j.ajkd.2013.01.024 PubMedCrossRef

15.

Liu QF, Ye JM, Yu LX, He AL, Sun Q, He DW, Li SS (2018) Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease. J Investig Med 66(3):669–675. https://doi.org/10.1136/jim-2017-000560 PubMedCrossRef

16.

Valenzuela PL, Cobo F, Diez-Vega I, Sanchez-Hernandez R, Pedrero-Chamizo R, Verde-Rello Z, Gonzalez-Gross M, Santiago C, Perez Ruiz M (2019) Physical performance, plasma S-klotho, and all-cause mortality in elderly dialysis patients: a prospective cohort study. Exp Gerontol 122:123–128. https://doi.org/10.1016/j.exger.2019.05.003 PubMedCrossRef

17.

Memmos E, Sarafidis P, Pateinakis P, Tsiantoulas A, Faitatzidou D, Giamalis P, Vasilikos V, Papagianni A (2019) Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis. BMC Nephrol 20(1):217. https://doi.org/10.1186/s12882-019-1391-1 PubMedPubMedCentralCrossRef

18.

Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605PubMedCrossRef

19.

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188PubMedCrossRef

20.

Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557. https://doi.org/10.1136/bmj.327.7414.557 PubMedPubMedCentralCrossRef

21.

Ding H-Y, Ma H-X (2015) Significant roles of anti-aging protein klotho and fibroblast growth factor 23 in cardiovascular disease. J Geriatr Cardiol 12(4):439–447. https://doi.org/10.11909/j.issn.1671-5411.2015.04.017 PubMedPubMedCentralCrossRef

22.

Kitagawa M, Sugiyama H, Nakamura K, Ito H, Makino H (2015) Soluble Klotho as biomarker of vascular dysfunction in chronic kidney disease. In: Preedy VR, Patel VB (eds) General methods in biomarker research and their applications. Springer, Netherlands, Dordrecht, pp 891–917. https://doi.org/10.1007/978-94-007-7696-8_44 CrossRef

23.

Kusaba T, Okigaki M, Matui A, Murakami M, Ishikawa K, Kimura T, Sonomura K, Adachi Y, Shibuya M, Shirayama T, Tanda S, Hatta T, Sasaki S, Mori Y, Matsubara H (2010) Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2 + channel to maintain endothelial integrity. Proc Natl Acad Sci U S A 107(45):19308–19313. https://doi.org/10.1073/pnas.1008544107 PubMedPubMedCentralCrossRef

24.

Martin A, David V, Quarles LD (2012) Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 92(1):131–155. https://doi.org/10.1152/physrev.00002.2011 PubMedCrossRef

25.

Hu MC, Kuro-o M, Moe OW (2012) Secreted klotho and chronic kidney disease. Adv Exp Med Biol 728:126–157. https://doi.org/10.1007/978-1-4614-0887-1_9 PubMedPubMedCentralCrossRef

26.

Wang Q, Su W, Shen Z, Wang R (2018) Correlation between soluble α-Klotho and renal function in patients with chronic kidney disease: a review and meta-Analysis. Biomed Res Int 2018:9481475. https://doi.org/10.1155/2018/9481475 PubMedPubMedCentralCrossRef

27.

Amaro-Gahete FJ, de-la-O A, Jurado-Fasoli L, Gutiérrez Á, Ruiz JR, Castillo MJ (2019) Association of physical activity and fitness with S-Klotho plasma levels in middle-aged sedentary adults: the FIT-AGEING study. Maturitas 123:25–31. https://doi.org/10.1016/j.maturitas.2019.02.001 PubMedCrossRef

28.

Kim HJ, Kang E, Oh YK, Kim YH, Han SH, Yoo TH, Chae D-W, Lee J, Ahn C, Oh K-H (2018) The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study. BMC Nephrol 19(1):51. https://doi.org/10.1186/s12882-018-0851-3 PubMedPubMedCentralCrossRef

29.

Patel MS, Donaldson AV, Lewis A, Natanek SA, Lee JY, Andersson YM, Haji G, Jackson SG, Bolognese BJ, Foley JP, Podolin PL, Bruijnzeel PLB, Hart N, Hopkinson NS, Man WDC, Kemp PR, Polkey MI (2016) Klotho and smoking—an interplay influencing the skeletal muscle function deficits that occur in COPD. Respir Med 113:50–56. https://doi.org/10.1016/j.rmed.2016.02.004 PubMedCrossRef

30.

Su X-M, Yang W (2014) Klotho protein lowered in elderly hypertension. Int J Clin Exp Med 7(8):2347–2350PubMedPubMedCentral

Titel: Lower circulating soluble Klotho level is associated with increased risk of all-cause mortality in chronic kidney disease patients: a systematic review and meta-analysis
verfasst von: Nipith Charoenngam
Ben Ponvilawan
Patompong Ungprasert
Publikationsdatum: 27.05.2020
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 8/2020
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-020-02510-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2020

Indoleamine 2,3-dioxygenase expression in the prognosis of the localized prostate cancer

Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy naïve patients

Potential mechanisms of uremic muscle wasting and the protective role of the mitochondria-targeted antioxidant Mito-TEMPO

Correction to: Interleukin 6 is a better predictor of 5-year cardiovascular mortality than high-sensitivity C-reactive protein in hemodialysis patients using reused low-flux dialyzers

The buccal belt: a buccal mucosal graft sub-coronal resurfacing for recurrent penile adhesions in patients with lichen sclerosus